







































Obeagu et al                                                                                                                                 Asian Journal of Dental and Health Sciences. 2024; 4(1):26-31 

[26]                                                                                                                                                                                                                                            AJDHS.COM 

 

 

Available online at ajdhs.com 

Asian Journal of Dental and Health Sciences 
Open Access to Dental and Medical Research 

Copyright  © 2024 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 
which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided 

the original author and source are credited  

 

 

The Vital Role of Blood Transfusions during Pregnancy: A Comprehensive 
Review 

*Emmanuel Ifeanyi Obeagu 1  and Getrude Uzoma Obeagu 2  
1 Department of Medical Laboratory Science, Kampala International University, Uganda,  

2 School of Nursing Science, Kampala International University, Uganda,  

Article Info: 
_____________________________________________ 
Article History: 

Received   21 December 2023     
Reviewed  18 January 2024 
Accepted   17 February 2024 
Published 15 March 2024 

_____________________________________________ 
Cite this article as:  

Obeagu EI, Obeagu GU, The Vital Role of Blood 
Transfusions during Pregnancy: A Comprehensive 
Review, Asian Journal of Dental and Health 
Sciences. 2024; 4(1):26-31 

DOI: http://dx.doi.org/10.22270/ajdhs.v4i1.58    

_____________________________________________ 

*Address for Correspondence:   

Emmanuel Ifeanyi Obeagu, Department of Medical 
Laboratory Science, Kampala International 
University, Uganda, 0000-0002-4538-0161 

Abstract 
_________________________________________________________________________________________________________________ 

Pregnancy is a remarkable yet complex physiological state that can be accompanied by various 
complications, including obstetric hemorrhage and severe anemia, which significantly affect 
maternal and fetal health. Blood transfusions serve as crucial interventions to manage these 
complications and mitigate potential risks. This comprehensive review synthesizes the pivotal role 
of blood transfusions during pregnancy, encompassing their indications, benefits, risks, and 
advancements in transfusion medicine. Exploring the multifaceted landscape of transfusions in 
addressing obstetric challenges, anemia, and other maternal conditions, this article underscores the 
paramount importance of timely and appropriate transfusion interventions to safeguard the health 
and well-being of both mother and child. Through an in-depth analysis of current knowledge and 
emerging trends, this review aims to provide a holistic understanding of the significance of blood 
transfusions in optimizing outcomes during pregnancy. 

Keywords: Blood Transfusions, Pregnancy, Maternal Health, Hemorrhage, Anemia, Obstetrics, Fetal 
Health, Transfusion Medicine 

 

Introduction  

Pregnancy is a transformative journey characterized by 
remarkable physiological changes to support the growth and 
development of the fetus. However, this period can also be 
fraught with potential complications that challenge maternal 
health and the well-being of the unborn child. Among these 
complications, obstetric hemorrhage and severe anemia stand 
as significant contributors to maternal morbidity and mortality 
worldwide.1-6 Obstetric hemorrhage, often unpredictable and 
rapid in onset, remains a leading cause of maternal mortality 
globally, accounting for approximately one-quarter of all 
pregnancy-related deaths. Additionally, anemia, prevalent 
among pregnant individuals due to increased blood volume 
demands and physiological changes, poses risks to both 
maternal and fetal health. Addressing these challenges 
effectively requires comprehensive strategies, and blood 
transfusions emerge as indispensable lifesaving 
interventions.7-12 

The administration of blood and blood products has 
revolutionized obstetric care, providing a crucial lifeline in 
managing acute blood loss, correcting anemia, and mitigating 
complications during pregnancy and childbirth. While the 
primary focus of blood transfusions is to stabilize maternal 
conditions, their impact extends to ensuring the optimal 
growth and development of the fetus.13-14 This paper aims to 
provide a comprehensive overview of the importance of blood 
transfusions during pregnancy. It will delve into the indications, 

benefits, and risks associated with transfusions in obstetric 
care. Furthermore, it will explore advancements in transfusion 
medicine, including emerging techniques and strategies, 
emphasizing their impact on maternal and fetal outcomes. 

Understanding the critical role of blood transfusions in 
pregnancy is essential not only for healthcare providers but 
also for policymakers and the broader community. By 
elucidating the significance of timely and appropriate 
transfusion interventions, this review aims to underscore the 
necessity of a multidisciplinary approach and continued 
advancements in transfusion practices to ensure the optimal 
health and well-being of pregnant individuals and their babies. 

Indications for Blood Transfusions during 
Pregnancy Obstetric hemorrhage 

Obstetric hemorrhage, characterized by excessive bleeding 
during pregnancy, childbirth, or the postpartum period, stands 
as a critical indication for blood transfusions. It represents a 
major cause of maternal morbidity and mortality globally. 
Various factors contribute to obstetric hemorrhage, including 
uterine atony, placental abnormalities, trauma, and surgical 
complications. Managing obstetric hemorrhage effectively 
often necessitates prompt and targeted interventions, with 
blood transfusions playing a pivotal role in stabilizing the 
patient and preventing severe complications.15-23 Postpartum 
hemorrhage resulting from uterine atony, a failure of the uterus 
to contract effectively after childbirth, is one of the most 
common causes of excessive bleeding. Transfusions are often 

                     Open Access                                                                                                                                                                                                           Review Article                                                                           

http://jddtonline.info/
http://dx.doi.org/10.22270/ajdhs.v4i1.58
https://crossmark.crossref.org/dialog/?doi=10.22270/ajdhs.v4i1.58&amp;domain=pdf
https://orcid.org/0000-0002-4538-0161
https://orcid.org/0000-0002-1373-9571


Obeagu et al                                                                                                                                 Asian Journal of Dental and Health Sciences. 2024; 4(1):26-31 

[27]                                                                                                                                                                                                                                            AJDHS.COM 

required when conventional measures like uterotonic 
medications fail to control bleeding.24-30 

Conditions such as placenta previa or placental abruption may 
lead to significant bleeding, requiring transfusions to address 
acute blood loss and maintain adequate perfusion to vital 
organs. In cases of obstetric trauma during childbirth or 
surgical complications, such as uterine rupture or severe 
lacerations, immediate transfusions may be necessary to 
stabilize the patient and restore blood volume.31-34 Transfusion 
protocols for obstetric hemorrhage involve rapid assessment, 
identification of the bleeding source, and simultaneous 
resuscitative measures. Timely administration of blood 
products, including packed red blood cells, fresh frozen plasma, 
platelets, and sometimes clotting factors, is essential to replace 
lost blood volume and correct coagulopathies.35-38 

Furthermore, a multidisciplinary approach involving 
obstetricians, hematologists, anesthesiologists, and blood bank 
specialists is crucial in optimizing transfusion therapy for 
obstetric hemorrhage. The aim is not only to prevent maternal 
complications but also to ensure the preservation of fetal well-
being during these critical moments. 

Benefits and Risks of Blood Transfusions in 
Pregnancy  

Blood transfusions during pregnancy carry both potential 
benefits and risks, necessitating careful consideration and 
individualized management based on the specific clinical 
circumstances. Understanding these aspects is crucial in 
optimizing maternal care while minimizing potential 
complications. 

Benefits: 

Blood transfusions serve as life-saving interventions in cases of 
obstetric hemorrhage, trauma, or severe postpartum 
hemorrhage, effectively restoring blood volume and preventing 
hypovolemic shock.39-41 Pregnant individuals may experience 
anemia due to factors such as iron deficiency, 
hemoglobinopathies, or other underlying conditions. 
Transfusions can rapidly replenish red blood cells and improve 
oxygen-carrying capacity, mitigating the risks associated with 
severe anemia for both the mother and the fetus.42-45 Timely 
transfusions help prevent complications related to inadequate 
tissue perfusion, organ dysfunction, and coagulopathies, 
reducing the risk of maternal morbidity and mortality.46 

Risks: 

Adverse reactions to transfusions, including febrile reactions, 
allergic reactions, hemolytic reactions, and transfusion-related 
acute lung injury (TRALI), pose risks to the recipient. Proper 
blood typing, cross-matching, and screening for antibodies are 
essential to minimize these risks.47 Despite stringent screening 
protocols, there remains a minimal risk of transmitting 
infectious agents through blood transfusions, including viruses 
(such as HIV, hepatitis B and C) and bacteria. Blood banks 
follow strict guidelines to minimize this risk. Transfusions can 
trigger immune responses leading to alloimmunization, where 
the recipient's immune system forms antibodies against 
transfused blood components. This may complicate future 
transfusions or pregnancies, potentially affecting fetal health in 
subsequent pregnancies.48 Rapid administration of large 
volumes of blood products can result in fluid overload, 
especially in individuals with compromised cardiac function, 
leading to pulmonary edema and exacerbating pre-existing 
conditions. To mitigate these risks and optimize benefits, 
healthcare providers must weigh the indications for 
transfusion against the potential complications. Individualized 
patient assessment, close monitoring, adherence to transfusion 
protocols, and ensuring compatibility and safety of blood 
products are critical in minimizing risks associated with 

transfusions during pregnancy. The decision to administer 
blood transfusions during pregnancy should involve a thorough 
risk-benefit analysis, considering the urgency of the situation, 
the patient's clinical status, and potential alternatives. Careful 
monitoring for adverse reactions and appropriate post-
transfusion care are imperative to ensure optimal outcomes for 
both the pregnant individual and the developing fetus. 

Advances in Transfusion Medicine and 
Pregnancy  

Transfusion medicine has witnessed significant advancements, 
revolutionizing approaches to blood product administration 
and transfusion strategies in obstetric care. These innovations 
aim to enhance safety, efficacy, and outcomes for pregnant 
individuals facing complications requiring blood 
transfusions.49-50 Improved understanding of blood component 
therapy has enabled more precise and tailored transfusion 
approaches. Specific components such as packed red blood 
cells, fresh frozen plasma, platelets, and cryoprecipitate can be 
administered based on individual patient needs, optimizing 
hemostasis and minimizing unnecessary transfusions.51 Rapid 
point-of-care testing methods have evolved, enabling timely 
assessment of coagulation parameters and hemoglobin levels. 
These advancements facilitate prompt decision-making in 
managing obstetric hemorrhage and anemia, allowing for 
targeted and personalized transfusion therapy.52 

Enhanced collaboration between transfusion medicine 
specialists and maternal-fetal medicine experts has led to 
improved understanding of the impact of transfusions on both 
maternal and fetal outcomes. This interdisciplinary approach 
considers the unique needs of both the pregnant individual and 
the developing fetus, ensuring comprehensive and balanced 
care.53 Implementation of pathogen reduction technologies in 
blood products has significantly reduced the risk of 
transfusion-transmitted infections. These technologies employ 
various methods to inactivate pathogens while preserving the 
integrity and functionality of blood components, enhancing the 
safety profile of transfusions.54 Patient Blood Management 
(PBM) Programs have gained prominence, focusing on 
optimizing patient outcomes by minimizing unnecessary 
transfusions, reducing exposure to blood products, and 
promoting alternative strategies such as iron supplementation, 
erythropoiesis-stimulating agents, and hemostatic agents.55 

Research into immunomodulation techniques aims to mitigate 
adverse immune reactions and alloimmunization in transfusion 
recipients. Strategies to induce immune tolerance to prevent 
alloimmunization are being explored, potentially impacting 
future transfusion and pregnancy outcomes.56 Ongoing 
research into blood substitutes and alternative oxygen-
carrying solutions aims to develop safer alternatives to 
traditional blood transfusions, reducing the risks associated 
with allogeneic blood products. These advances underscore the 
dynamic nature of transfusion medicine in pregnancy. 
Implementing these innovations requires ongoing research, 
multidisciplinary collaboration, and adherence to evolving best 
practices. By embracing these advancements, healthcare 
providers can optimize transfusion therapy, ensuring safer and 
more effective care for pregnant individuals facing obstetric 
complications that necessitate blood transfusions. 

Impact on Maternal and Fetal Health  

The impact of blood transfusions on maternal and fetal health 
during pregnancy is multifaceted and warrants careful 
consideration, as these interventions directly influence the 
well-being of both the pregnant individual and the developing 
fetus. 

 



Obeagu et al                                                                                                                                 Asian Journal of Dental and Health Sciences. 2024; 4(1):26-31 

[28]                                                                                                                                                                                                                                            AJDHS.COM 

Maternal Health: 

Blood transfusions play a crucial role in stabilizing maternal 
conditions during obstetric hemorrhage. Prompt 
administration of blood products helps restore blood volume, 
ensuring adequate tissue perfusion and mitigating the risk of 
maternal morbidity and mortality. Severe anemia in pregnancy 
poses risks to maternal health, including fatigue, cardiac strain, 
and impaired oxygen delivery to tissues. Transfusions can 
rapidly address anemia, improving maternal well-being and 
reducing the risk of complications. Transfusions help prevent 
or mitigate complications associated with hypovolemia, 
inadequate oxygenation, and coagulopathies, reducing the risk 
of organ dysfunction and improving overall maternal 
outcomes.57 

Fetal Health: 

Maternal blood transfusions enhance oxygen-carrying capacity, 
ensuring improved oxygen delivery to the placenta and 
subsequently to the developing fetus. This is particularly 
beneficial in cases of maternal anemia, optimizing fetal growth 
and development. While transfusions primarily focus on 
maternal stabilization, their effects extend to the fetus. Timely 
interventions can indirectly mitigate potential fetal 
complications resulting from maternal distress due to 
hemorrhage or anemia.58 

Balancing Maternal and Fetal Well-Being 

Optimizing maternal health through transfusions is crucial for 
ensuring a favorable intrauterine environment for the 
developing fetus. However, healthcare providers must carefully 
weigh the benefits of transfusions for the mother against 
potential risks to the fetus, considering factors such as 
gestational age, indications for transfusion, and the overall 
health status of both the mother and the fetus.59 Monitoring 
fetal well-being during and after transfusions through 
techniques like fetal heart rate monitoring and ultrasound 
assessments is vital. Multidisciplinary collaboration between 
obstetricians, hematologists, neonatologists, and other 
specialists ensures comprehensive care, aiming to minimize 
risks to the fetus while addressing maternal health concerns.60-

61 Understanding the interconnectedness of maternal and fetal 
health in the context of blood transfusions during pregnancy 
underscores the importance of individualized care, close 
monitoring, and informed decision-making to optimize 
outcomes for both the mother and the unborn child. 

Ethical and Societal Perspectives  

Ethical and societal perspectives surrounding blood 
transfusions during pregnancy are integral aspects that 
influence decision-making, healthcare delivery, and patient 
outcomes. Respecting the autonomy of pregnant individuals in 
decision-making regarding transfusions is crucial. Healthcare 
providers must ensure that individuals are adequately 
informed about the risks, benefits, and alternatives to 
transfusions, considering religious, cultural, and personal 
beliefs that may impact their acceptance of this intervention.62 
The ethical principles of beneficence (doing good) and non-
maleficence (avoiding harm) guide healthcare professionals in 
balancing the benefits of transfusions for maternal health 
against potential risks to both the mother and the fetus. Striking 
this balance requires a careful evaluation of the clinical 
situation while prioritizing the well-being of both patients.62 

Religious beliefs and cultural norms significantly influence 
attitudes toward blood transfusions during pregnancy. Certain 
religious groups have prohibitions or reservations against 
blood transfusions, necessitating respectful dialogue, and 
alternative approaches to care that align with patients' beliefs. 
Ensuring equitable access to transfusion services is essential. 

Socioeconomic factors, geographical location, and healthcare 
disparities may affect access to timely transfusions. Efforts to 
provide access to safe and culturally sensitive transfusion 
services are imperative to prevent adverse maternal and fetal 
outcomes. Legal frameworks govern healthcare decisions, 
including transfusions during pregnancy. Healthcare providers 
must adhere to established guidelines, ensuring patient safety 
and respecting patient rights, including the right to refuse 
treatment based on religious or personal beliefs. Public 
awareness and education campaigns are vital to dispel 
misconceptions, increase awareness about the importance of 
blood transfusions in pregnancy, and foster understanding and 
support within communities. This helps address stigmas or 
fears surrounding transfusions and encourages informed 
decision-making. 

Ethical considerations in research involving transfusions 
during pregnancy involve safeguarding the rights and well-
being of pregnant participants. Ethical research practices 
ensure that advancements in transfusion medicine benefit 
pregnant individuals without undue risks. Navigating these 
ethical and societal considerations demands a patient-centered 
approach that respects cultural diversity, promotes patient 
autonomy, and upholds ethical principles while delivering 
optimal healthcare. Collaboration among healthcare providers, 
ethicists, community leaders, and policymakers is crucial in 
developing inclusive policies and practices that respect 
patients' beliefs while ensuring the best possible care outcomes 
for pregnant individuals requiring blood transfusions. 

Future Directions 

Future directions in blood transfusions during pregnancy are 
poised to bring about significant advancements in maternal and 
fetal care.  Advances in technology and understanding of 
individual patient factors (such as genetics, immunology, and 
hemodynamics) may lead to tailored transfusion approaches. 
Precision medicine principles could enable customized 
transfusion therapies based on specific patient needs, 
minimizing risks and optimizing outcomes. Ongoing research 
aims to further reduce the risks associated with transfusions, 
including efforts to enhance blood safety, prevent transfusion 
reactions, and develop alternative transfusion products or 
strategies that minimize immunological responses. 

Research into non-blood alternatives, such as synthetic oxygen 
carriers, hemoglobin-based oxygen carriers, and oxygen 
therapeutics, continues to advance. These alternatives aim to 
provide oxygen-carrying capacity without the risks associated 
with traditional blood transfusions. Strategies to modulate the 
immune response and prevent alloimmunization post-
transfusion are under exploration. Novel techniques may aim 
to induce immune tolerance, reducing the risks of adverse 
reactions and sensitization in pregnant individuals. 
Advancements in point-of-care testing technologies are 
expected to further improve the rapid assessment of 
hemoglobin levels, coagulation parameters, and immunological 
responses. This will facilitate real-time decision-making and 
personalized transfusion interventions. 

Integration of telemedicine and remote consultation services 
could enhance access to expert guidance in managing obstetric 
complications necessitating transfusions, especially in 
underserved or remote areas lacking immediate access to 
specialized care. Continued research focusing on the long-term 
maternal and fetal outcomes following blood transfusions 
during pregnancy is essential. Studying the potential effects on 
subsequent pregnancies, immune sensitization, and overall 
health of both mother and child will provide valuable insights. 
Further exploration into ethical dilemmas, cultural 
sensitivities, and religious perspectives regarding blood 
transfusions in pregnancy is critical. Policies and practices 



Obeagu et al                                                                                                                                 Asian Journal of Dental and Health Sciences. 2024; 4(1):26-31 

[29]                                                                                                                                                                                                                                            AJDHS.COM 

should evolve to respect diverse beliefs while ensuring optimal 
care. 

The future of transfusion medicine in pregnancy lies in 
advancing safety, efficacy, and individualized care. 
Collaborative efforts among researchers, healthcare providers, 
policymakers, and communities will drive these advancements, 
shaping the landscape of maternal-fetal medicine and 
transfusion practices for improved outcomes and patient-
centered care. Continued innovation and research in these 
areas will further refine and enhance transfusion therapies for 
pregnant individuals facing obstetric challenges. 

Recommendations 

Recommendations concerning blood transfusions during 
pregnancy encompass a multifaceted approach aimed at 
optimizing care, ensuring patient safety, and improving 
outcomes. Encourage the establishment of multidisciplinary 
teams comprising obstetricians, hematologists, 
anesthesiologists, neonatologists, and transfusion specialists. 
Collaborative efforts ensure comprehensive care, facilitating 
timely decision-making and optimal management of pregnant 
individuals requiring blood transfusions. Develop evidence-
based protocols and clinical guidelines specific to blood 
transfusions during pregnancy. These guidelines should 
encompass indications, dosing, monitoring, and adverse event 
management, ensuring standardized and safe practices across 
healthcare settings. Emphasize patient-centered 
communication and informed consent processes. Healthcare 
providers should engage in open discussions with pregnant 
individuals, respecting their beliefs, preferences, and concerns 
regarding transfusions. Providing clear, understandable 
information aids in informed decision-making. 

Offer continuous education and training programs for 
healthcare professionals involved in obstetric care. These 
programs should focus on transfusion protocols, ethical 
considerations, cultural competency, and advancements in 
transfusion medicine, enhancing the quality of care provided to 
pregnant patients. Ensure equitable access to safe and 
culturally sensitive transfusion services, especially in 
underserved or remote areas. Addressing healthcare 
disparities and ensuring access to timely transfusions can 
significantly impact maternal and fetal outcomes. Encourage 
and support research endeavors focusing on transfusion 
medicine in pregnancy. Research initiatives should explore 
alternative transfusion strategies, long-term outcomes, 
immunomodulation techniques, and safety measures to 
continually improve transfusion practices and minimize risks. 

Develop policies that balance patient autonomy, safety, and 
ethical considerations surrounding transfusions during 
pregnancy. These policies should respect diverse cultural and 
religious beliefs while prioritizing maternal and fetal well-
being. Foster public awareness campaigns highlighting the 
importance of blood transfusions in pregnancy. Promote 
community support, dispel myths, and encourage dialogue to 
increase acceptance and understanding of transfusions among 
diverse populations. By implementing these recommendations, 
healthcare systems can enhance the quality of care provided to 
pregnant individuals, ensure patient safety, and improve 
outcomes associated with obstetric complications requiring 
blood transfusions. Continuous evaluation and adaptation of 
practices based on emerging evidence and ethical 
considerations are essential to advancing transfusion medicine 
in the context of pregnancy. 

Conclusion 

The significance of blood transfusions during pregnancy cannot 
be overstated in safeguarding the health and well-being of both 
the pregnant individual and the developing fetus. Obstetric 

complications such as hemorrhage and severe anemia pose 
substantial risks, necessitating prompt and effective 
interventions, where blood transfusions play a pivotal role. 
Striking a balance between optimizing maternal health and 
ensuring fetal well-being remains a core challenge. This balance 
necessitates a personalized, patient-centered approach that 
respects individual beliefs, preferences, and cultural 
considerations. Multidisciplinary collaboration, evidence-
based protocols, and continuous advancements in technology 
and research are critical to evolving transfusion practices, 
minimizing risks, and improving outcomes. Ultimately, the 
comprehensive understanding and application of 
advancements in transfusion medicine during pregnancy 
underscore the commitment to providing optimal care. By 
embracing emerging knowledge, fostering collaboration, and 
advocating for patient-centered approaches, we pave the way 
for continued advancements that ensure the well-being of 
pregnant individuals and their babies, embodying the essence 
of compassionate and evidence-based obstetric care. 

Acknowledgements 

Not applicable 

Authors contribution 

All the authours were involved in conceptualisation, 
methodology, visualization, validation, drafting and editing of 
the article 

Funding source 

No fund was received to write this paper 

Conflict of Interest 

The authors declare that they have no conflict interests. 

Ethical Clearance 

Not applicable 

References 

1. Obeagu EI, Agreen FC. Anaemia among pregnant women: A review 
of African pregnant teenagers. J Pub Health Nutri. 2023; 6 (1). 
2023;138. links/63da799664fc860638054562/Anaemia-among-
pregnant-women-A-review-of-African-pregnant-teenagers.pdf. 

2. Obeagu EI, Ezimah AC, Obeagu GU. Erythropoietin in the anaemias 
of pregnancy: a review. Int J Curr Res Chem Pharm Sci. 
2016;3(3):10-18. 
links/5710fae108ae846f4ef05afb/ERYTHROPOIETIN-IN-THE-
ANAEMIAS-OF-PREGNANCY-A-REVIEW.pdf. 

3. Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, Okpala 
PU, Agu CC. Assessment of Haematological Changes in Pregnant 
Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci. 2021 
Apr;9(4):145-8. links/608a6728a6fdccaebdf52d94/Assessment-
of-Haematological-Changes-in-Pregnant-Women-of-Ido-Ondo.pdf. 

4. Obeagu EI, Obeagu GU. Sickle Cell Anaemia in Pregnancy: A Review. 
International Research in Medical and Health Sciences. 2023 Jun 
10;6(2):10-13. 
http://irmhs.com/index.php/irmhs/article/view/111. 

5. Jakheng SP, Obeagu EI. Seroprevalence of human immunodeficiency 
virus based on demographic and risk factors among pregnant 
women attending clinics in Zaria Metropolis, 1Nigeria. J Pub 
Health Nutri. 2022;5(8):2022;137. 
https://6317a6b1acd814437f0ad268/Seroprevalence-of-human-
immunodeficiency-virus-based-on-demographic-and-risk-factors-
among-pregnant-women-attending-clinics-in-Zaria-Metropolis-
Nigeria.pdf   https://doi.org/10.9734/sajrm/2022/v13i230295 

6. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF. 
Evaluation of Protein C, Protein S and Fibrinogen of Pregnant 
Women with Malaria in Owerri Metropolis. Madonna University 

https://6317a6b1acd814437f0ad268/Seroprevalence-of-human-immunodeficiency-virus-based-on-demographic-and-risk-factors-among-pregnant-women-attending-clinics-in-Zaria-Metropolis-Nigeria.pdf
https://6317a6b1acd814437f0ad268/Seroprevalence-of-human-immunodeficiency-virus-based-on-demographic-and-risk-factors-among-pregnant-women-attending-clinics-in-Zaria-Metropolis-Nigeria.pdf
https://6317a6b1acd814437f0ad268/Seroprevalence-of-human-immunodeficiency-virus-based-on-demographic-and-risk-factors-among-pregnant-women-attending-clinics-in-Zaria-Metropolis-Nigeria.pdf
https://6317a6b1acd814437f0ad268/Seroprevalence-of-human-immunodeficiency-virus-based-on-demographic-and-risk-factors-among-pregnant-women-attending-clinics-in-Zaria-Metropolis-Nigeria.pdf
https://doi.org/10.9734/sajrm/2022/v13i230295


Obeagu et al                                                                                                                                 Asian Journal of Dental and Health Sciences. 2024; 4(1):26-31 

[30]                                                                                                                                                                                                                                            AJDHS.COM 

journal of Medicine and Health Sciences ISSN: 2814-3035. 
2022;2(2):1-9. 

7. Villa CH, Anselmo AC, Mitragotri S, Muzykantov V. Red blood cells: 
Supercarriers for drugs, biologicals, and nanoparticles and 
inspiration for advanced delivery systems. Advanced drug 
delivery reviews, 2016; 106, 88-103. 
https://doi.org/10.1016/j.addr.2016.02.007 PMid:26941164 
PMCid:PMC5424548 

8. Ross PT. Risking reproduction reproductive health among women 
with sickle cell disease. Wayne State University. 2013. 

9. Obeagu EI, Ezimah AC, Obeagu GU. Erythropoietin in the anaemias 
of pregnancy: a review. Int J Curr Res Chem Pharm Sci, 2016; 3(3), 
10-8. 

10. Obeagu EI, Agreen FC. Anaemia among pregnant women: A review 
of African pregnant teenagers. J Pub Health Nutri. 2023; 6 (1), 138. 

11. Obeagu EI, Ogunnaya FU. Pregnancyinduced Haematological 
Changes: A Key to Marternal and Child Health. European Journal 
of Biomedical, 2023; 10(8), 42-3. 

12. Obeagu EI, Hassan AO, Adepoju OJ, Obeagu GU, Okafor CJ. 
Evaluation of Changes in Haematological Parameters of Pregnant 
Women Based on Gestational Age at Olorunsogo Road Area of Ido, 
Ondo State. Nigeria. Journal of Research in Medical and Dental 
Science, 2021; 9(12), 462-4. 
https://doi.org/10.9734/jpri/2022/v34i12A35546 

13. Kelly SE. The maternal-foetal interface and gestational chimerism: 
the emerging importance of chimeric bodies. Science as Culture, 
2012; 21(2), 233-257. 
https://doi.org/10.1080/09505431.2011.628014 

14. Sharma S, Banerjee S, Krueger PM, Blois SM. Immunobiology of 
gestational diabetes mellitus in post-medawar era. Frontiers in 
Immunology, 2022; 12, 758267. 
https://doi.org/10.3389/fimmu.2021.758267 PMid:35046934 
PMCid:PMC8761800 

15. Osborne C, Kolakowski M, Lobenstine D. Pre-and Perinatal 
Massage Therapy: A Comprehensive Guide to Prenatal, Labor and 
Postpartum Practice. Jessica Kingsley Publishers. 2021. 

16. Gamde MS, Obeagu EI. Iron Deficiency Anaemia: Enemical to 
Pregnancy. European Journal of Biomedical, 2023; 10(9), 272-275. 

17. Obeagu EI, Hassan AO, Adepoju OJ, Obeagu GU, Okafor CJ. 
Evaluation of Changes in Haematological Parameters of Pregnant 
Women Based on Gestational Age at Olorunsogo Road Area of Ido, 
Ondo State. Nigeria. Journal of Research in Medical and Dental 
Science. 2021;9(12):462-. 
https://doi.org/10.9734/jpri/2022/v34i12A35546 

18. Obeagu EI, Ikpenwa JN, Chukwueze CM, Obeagu GU. Evaluation of 
protein C, protein S and fibrinogen of pregnant women in Owerri 
Metropolis. Madonna University Journal of Medicine and Health 
Sciences, 2022; 2(1): 292-298. 

19. Obeagu EI. Comparative Study of Serum Iron and Hemoglobin 
Levels of Cord Blood of Normal Neonates and that of Maternal 
Blood in Federal Medical Centre Owerri. Journal of Clinical and 
Laboratory Research, 2021;4(1): 2768-0487. 

20. Anyiam AF, Obeagu EI, Obi E, Omosigho PO, Irondi EA, Arinze-
Anyiam OC, Asiyah MK. ABO blood groups and gestational 
diabetes among pregnant women attending University of Ilorin 
Teaching Hospital, Kwara State, Nigeria. International Journal of 
Research and Reports in Hematology, 2022; 5(2), 113-121. 

21. Obeagu EI. Gestational Thrombocytopaenia. J Gynecol Women's 
Health, 2023; 25(3), 556163. 
https://doi.org/10.19080/JGWH.2023.25.556163 

22. Jakheng SPE, Obeagu EI. Seroprevalence of human 
immunodeficiency virus based on demographic and risk factors 
among pregnant women attending clinics in Zaria Metropolis, 
Nigeria. J Pub Health Nutri. 2022; 5 (8), 137. 
https://doi.org/10.9734/sajrm/2022/v13i230295 

23. Obeagu EI, Gamade SM, Obeagu GU. The roles of Neutrophils in 
pregnancy. Int. J. Curr. Res. Med. Sci, 2023; 9(5), 31-35. 

24. Orefice R. Immunology and the immunological response in 
pregnancy. Best practice & research Clinical obstetrics & 
gynaecology, 2021; 76, 3-12. 
https://doi.org/10.1016/j.bpobgyn.2020.07.013 PMid:33191116 

25. Robertson SA, Care AS, Moldenhauer LM. Regulatory T cells in 
embryo implantation and the immune response to pregnancy. The 
Journal of clinical investigation, 2018;128(10), 4224-4235. 
https://doi.org/10.1172/JCI122182 PMid:30272581 
PMCid:PMC6159994 

26. Burton GJ, Fowden AL, Thornburg KL. Placental origins of chronic 
disease. Physiological reviews, 2016; 96(4), 1509-1565. 
https://doi.org/10.1152/physrev.00029.2015 PMid:27604528 
PMCid:PMC5504455 

27. Chighizola CB, Lonati PA, Trespidi L, Meroni PL, Tedesco F. The 
complement system in the pathophysiology of pregnancy and in 
systemic autoimmune rheumatic diseases during pregnancy. 
Frontiers in immunology, 2020; 11, 2084. 
https://doi.org/10.3389/fimmu.2020.02084 PMid:32973817 
PMCid:PMC7481445 

28. Robinson DP, Klein SL. Pregnancy and pregnancy-associated 
hormones alter immune responses and disease pathogenesis. 
Hormones and behavior, 2012; 62(3), 263-271. 
https://doi.org/10.1016/j.yhbeh.2012.02.023 PMid:22406114 
PMCid:PMC3376705 

29. Okorie HM, Obeagu EI, Obarezi HC, Anyiam AF. Assessment of 
some inflammatory cytokines in malaria infected pregnant 
women in Imo State Nigeria. International Journal of Medical 
Science and Dental Research, 2019; 2(1), 25-36. 

30. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM. Evaluation of levels 
of some inflammatory cytokines in preeclamptic women in 
owerri. Journal of Pharmaceutical Research International, 2021; 
33(42A), 53-65. 
https://doi.org/10.9734/jpri/2021/v33i42A32384 

31. Ifeanyi OE, Vincent CCN, Ugochi CMJ. Studies on some cytokines of 
apparently healthy Nigerian women aged 10-40 years. Int. J. Curr. 
Res. Med. Sci, 2019; 5(12), 24-30. 

32. Obeagu EI, Okoroiwu IL, Obeagu GU. Relationship between 
Thrombopoietin and Interleukin 3: A Review. Int J Curr Res Chem 
Pharm. Sci, 2022; 9(1), 7-13. 

33. Obeagu EI, Muhimbura E, Kagenderezo BP, Nakyeyune S, Obeagu 
GU. An Insight of Interleukin-6 and Fibrinogen: In Regulating the 
Immune System. J Biomed Sci, 2022; 11(10), 83. 

34. Ifeanyi O, Uzoma O, Amaeze A, Ijego A, Felix C, Ngozi A, ... Chinenye 
K. Maternal expressions (serum levels) of alpha tumour necrosis 
factor, interleukin 10, interleukin 6 and interleukin 4 in malaria 
infected pregnant women based on parity in a Tertiary Hospital in 
Southeast, Nigeria. Journal of Pharmaceutical Research 
International, 2020; 32(23), 35-41. 
https://doi.org/10.9734/jpri/2020/v32i2330786 

35. Obeagu E, Felix CE, MTB O, Chikodili UM, Nchekwubedi CS, 
Chinedum OK. Studies on some cytokines, CD4, iron status, 
hepcidin and some haematological parameters in pulmonary 
tuberculosis patients based on duration of treatment in Southeast, 
Nigeria. African Journal of Biological Sciences, 2021; 3(1), 146-
156. https://doi.org/10.33472/AFJBS.3.1.2021.146-156 

36. Obeagu EI, Amedu GO, Okoroiwu IL, Okafor CJ, Okun O, Ochiabuto 
OM, Ukeekwe CO. Evaluation of plasma levels of interleukin 6 and 
iron status of football players in a Nigerian university. Journal of 
Pharmaceutical Research International, 2021; 33(59B), 383-388. 
https://doi.org/10.9734/jpri/2021/v33i59B34393 

37. Obeagu EI, Obeagu GU, Guevara MEC, Okafor CJ, Bot YS, Eze GC, ... 
Uwakwe OS. Evaluation of Plasma Levels of Interleukin 6 and Iron 
of Volleyball Players Based on Heights and Weight of a Nigerian 
University Students. Asian Journal of Medicine and Health, 2022; 
20(10), 147-152. 
https://doi.org/10.9734/ajmah/2022/v20i1030515 

38. Macpherson AJ, de Agüero MG, Ganal-Vonarburg SC. How nutrition 
and the maternal microbiota shape the neonatal immune system. 
Nature Reviews Immunology, 2017; 17(8), 508-517. 
https://doi.org/10.1038/nri.2017.58 PMid:28604736 

https://doi.org/10.1016/j.addr.2016.02.007
https://doi.org/10.9734/jpri/2022/v34i12A35546
https://doi.org/10.1080/09505431.2011.628014
https://doi.org/10.3389/fimmu.2021.758267
https://doi.org/10.9734/jpri/2022/v34i12A35546
https://doi.org/10.19080/JGWH.2023.25.556163
https://doi.org/10.9734/sajrm/2022/v13i230295
https://doi.org/10.1016/j.bpobgyn.2020.07.013
https://doi.org/10.1172/JCI122182
https://doi.org/10.1152/physrev.00029.2015
https://doi.org/10.3389/fimmu.2020.02084
https://doi.org/10.1016/j.yhbeh.2012.02.023
https://doi.org/10.9734/jpri/2021/v33i42A32384
https://doi.org/10.9734/jpri/2020/v32i2330786
https://doi.org/10.33472/AFJBS.3.1.2021.146-156
https://doi.org/10.9734/jpri/2021/v33i59B34393
https://doi.org/10.9734/ajmah/2022/v20i1030515
https://doi.org/10.1038/nri.2017.58


Obeagu et al                                                                                                                                 Asian Journal of Dental and Health Sciences. 2024; 4(1):26-31 

[31]                                                                                                                                                                                                                                            AJDHS.COM 

39. García-Roa M, del Carmen Vicente-Ayuso M, Bobes AM, Pedraza 
AC, González-Fernández A, Martín MP, ... Gutiérrez L. Red blood 
cell storage time and transfusion: current practice, concerns and 
future perspectives. Blood Transfusion, 2017; 15(3), 222. 

40. Obeagu EI, Babar Q, Obeagu GU. Allergic blood Transfusion 
reaction: A Review. Int. J. Curr. Res. Med. Sci. 2021; 7(5):25-33. 

41. Obeagu EI, Oshim IO, Ochei KC, Obeagu GU. Iron and blood 
donation: A Review. Int. J. Curr. Res. Med. Sci. 2016; 2(10):16-48. 

42. Okoroiwu IL, Obeagu EI, Elemchukwu Q, Ochei KC, Christian GS. 
Frequency of Transfusion Reactions Following Compatible Cross 
Matching of Blood: A Study in Owerri Metropolis. International 
Journal of Current Research and Academic Review. 2015; 
3(1):155-60. 

43. Ogar CO, Okoroiwu HU, Obeagu EI, Etura JE, Abunimye DA. 
Assessment of blood supply and usage pre-and during COVID-19 
pandemic: a lesson from non-voluntary donation. Transfusion 
Clinique et Biologique. 2021; 28(1):68-72. 
https://doi.org/10.1016/j.tracli.2020.10.004 PMid:33080420 
PMCid:PMC7836417 

44. Brand A. Immunological complications of blood transfusions. La 
Presse Médicale, 2016; 45(7-8), e313-e324. 
https://doi.org/10.1016/j.lpm.2016.06.024 PMid:27499223 

45. Montgomery RA, Tatapudi VS, Leffell MS, Zachary AA. HLA in 
transplantation. Nature reviews nephrology, 2018; 14(9), 558-
570. https://doi.org/10.1038/s41581-018-0039-x 
PMid:29985463 

46. Neal MD, Raval JS, Triulzi DJ, Simmons RL. Innate immune 
activation after transfusion of stored red blood cells. Transfusion 
medicine reviews, 2013; 27(2), 113-118. 
https://doi.org/10.1016/j.tmrv.2013.01.001 PMid:23434246 

47. Tormey CA, Hendrickson JE.Transfusion-related red blood cell 
alloantibodies: induction and consequences. Blood, The Journal of 
the American Society of Hematology, 2019; 133(17), 1821-1830. 
https://doi.org/10.1182/blood-2018-08-833962 PMid:30808636 
PMCid:PMC6484385 

48. Johnsen J. Pathogenesis in immune thrombocytopenia: new 
insights. Hematology 2010, the American Society of Hematology 
Education Program Book, 2012(1): 306-312. 
https://doi.org/10.1182/asheducation.V2012.1.306.3798320 
PMid:23233597 

49. Remy KE, Hall MW, Cholette J, Juffermans NP, Nicol K, Doctor A. 
Pediatric Critical Care Blood Research Network (Blood Net). 
Mechanisms of red blood cell transfusion-related 
immunomodulation. Transfusion, 2018; 58(3), 804-815. 
https://doi.org/10.1111/trf.14488 PMid:29383722 
PMCid:PMC6592041 

50. Alegre ML, Lakkis FG, Morelli AE. Antigen presentation in 
transplantation. Trends in immunology, 2016; 37(12), 831-843. 
https://doi.org/10.1016/j.it.2016.09.003 PMid:27743777 
PMCid:PMC5135637 

51. Davenport RD. An introduction to chemokines and their roles in 
transfusion medicine. Vox sanguinis, 2009; 96(3), 183-198. 
https://doi.org/10.1111/j.1423-0410.2008.01127.x 
PMid:19076338 

52. Brown CJ, Navarrete CV. Clinical relevance of the HLA system in 
blood transfusion. Vox sanguinis, 2011; 101(2), 93-105. 
https://doi.org/10.1111/j.1423-0410.2011.01474.x 
PMid:21535436 

53. Leventhal JS, Schröppel B. Toll-like receptors in transplantation: 
sensing and reacting to injury. Kidney international, 2012; 81(9), 
826-832. https://doi.org/10.1038/ki.2011.498 PMid:22297675 

54. Hendrickson JE, Tormey CA. Understanding red blood cell 
alloimmunization triggers. Hematology 2014, the American 
Society of Hematology Education Program Book, 2016(1), 446-
451. https://doi.org/10.1182/asheducation-2016.1.446 
PMid:27913514 PMCid:PMC6142457 

55. Sarkesh A, Sorkhabi AD, Ahmadi H, Abdolmohammadi-Vahid S, 
Parhizkar F, Yousefi M. Aghebati-Maleki L. Allogeneic lymphocytes 
immunotherapy in female infertility: lessons learned and the road 
ahead. Life Sciences, 2022; 299, 120503. 
https://doi.org/10.1016/j.lfs.2022.120503 PMid:35381221 

56. Aguilar-Nascimento JE, Zampieri-Filho JP, Bordin J O. Implications 
of perioperative allogeneic red blood cell transfusion on the 
immune-inflammatory response. Hematology, Transfusion and 
Cell Therapy, 2021; 43: 58-64. 
https://doi.org/10.1016/j.htct.2020.03.003 PMid:32532624 
PMCid:PMC7910182 

57. Vamvakas EC, Blajchman MA. Deleterious clinical effects of 
transfusion-associated immunomodulation: fact or fiction? Blood, 
The Journal of the American Society of Hematology, 2001; 97(5), 
1180-1195. https://doi.org/10.1182/blood.V97.5.1180 
PMid:11222359 

58. Tormey CA, Hendrickson JE. Transfusion-related red blood cell 
alloantibodies: induction and consequences. Blood, The Journal of 
the American Society of Hematology, 2019; 133(17): 1821-1830. 
https://doi.org/10.1182/blood-2018-08-833962 PMid:30808636 
PMCid:PMC6484385 

59. Gonzalez CA, Gonzalez S. Fetal and neonatal allo-immune response. 
Transfusion and Apheresis Science, 2020; 59(5): 102945. 
https://doi.org/10.1016/j.transci.2020.102945 PMid:32958398 

60. Brown JB, Neal MD, Guyette FX, Peitzman AB, Billiar TR, 
Zuckerbraun BS, Sperry J. L. Design of the study of tranexamic acid 
during air medical prehospital transport (STAAMP) trial: 
addressing the knowledge gaps. Prehospital Emergency Care, 
2015; 19(1), 79-86. 
https://doi.org/10.3109/10903127.2014.936635 
PMid:25076119 PMCid:PMC4623322 

61. Yusoff SM, Bahar R, Hassan MN, Noor NHM, Ramli M, Shafii NF. 
Prevalence of red blood cell alloimmunization among transfused 
chronic kidney disease patients in hospital Universiti Sains 
Malaysia. Oman medical journal, 2020; 35(5): e177. 
https://doi.org/10.5001/omj.2020.95 PMid:33083035 
PMCid:PMC7538639 

62. Day JD, Cockrell C, Namas R, Zamora R, An G, Vodovotz Y. 
Inflammation and disease: modelling and modulation of the 
inflammatory response to alleviate critical illness. Current opinion 
in systems biology, 2018; 12, 22-29. 
https://doi.org/10.1016/j.coisb.2018.08.008 PMid:30886940 
PMCid:PMC6420220

 

 

https://doi.org/10.1016/j.tracli.2020.10.004
https://doi.org/10.1016/j.lpm.2016.06.024
https://doi.org/10.1038/s41581-018-0039-x
https://doi.org/10.1016/j.tmrv.2013.01.001
https://doi.org/10.1182/blood-2018-08-833962
https://doi.org/10.1182/asheducation.V2012.1.306.3798320
https://doi.org/10.1111/trf.14488
https://doi.org/10.1016/j.it.2016.09.003
https://doi.org/10.1111/j.1423-0410.2008.01127.x
https://doi.org/10.1111/j.1423-0410.2011.01474.x
https://doi.org/10.1038/ki.2011.498
https://doi.org/10.1182/asheducation-2016.1.446
https://doi.org/10.1016/j.lfs.2022.120503
https://doi.org/10.1016/j.htct.2020.03.003
https://doi.org/10.1182/blood.V97.5.1180
https://doi.org/10.1182/blood-2018-08-833962
https://doi.org/10.1016/j.transci.2020.102945
https://doi.org/10.3109/10903127.2014.936635
https://doi.org/10.5001/omj.2020.95
https://doi.org/10.1016/j.coisb.2018.08.008

